Aaron Fobian, Ph.D., assistant professor in the Department of Psychiatry and Behavioral Neurobiology and researcher at the UAB School of Health Professions’ Nutrition Obesity Research Center, has been elected Councilor for The Obesity Society — Pediatric Obesity Section. Her term began Nov. 1, and she will serve for the next two years.
Will Ferniany, CEO of the UAB Health System, has been named to the 2017 list of Becker's Hospital Review's “183 nonprofit hospital and health system CEOs to know.”
Michael Cox became the UAB Division of Transplantation’s 10,000th patient to receive a kidney transplant thanks to the generosity of a deceased donor. Tony Adams became kidney transplant recipient No. 10,001, with his gift coming from a living donor — his brother, Daniel. The transplants make UAB one of only three U.S. transplant programs to cross the 10,000-kidney transplant mark.
William A. Curry, M.D., MACP, has been elected Governor of the Alabama Chapter of the American College of Physicians, the national organization of internists. Curry will serve a year as Governor-elect, after which he will succeed UAB colleague Gustavo R. Heudebert, M.D., MACP, in the role.
UAB Cancer Center’s lay navigation program honored with prestigious Innovator Award
Written by Beena Thannickal
The UAB Comprehensive Cancer Center has received a prominent national Innovator Award from the Association of Community Cancer Centers (ACCC) for its Patient Care Connect Program. The award is given only to ACCC members that are forward-thinking in creating replicable solutions to improve access, quality and value of patient care.
The Lupus Research Alliance recently awarded UAB a one-year grant of $250,000 to investigate a new explanation for how lupus develops and the reason some people, particularly African-Americans, are at a greater risk for flare-ups and kidney disease.
The UAB Department of Surgery has joined the National Institutes of Health SIREN network. SIREN will coordinate and lead high-quality multisite clinical trials to improve outcomes for patients who experience neurologic, cardiac, respiratory, hematologic and trauma emergency events.
Daniel Gorelick, Ph.D., assistant professor of pharmacology and toxicology at UAB, has created zebrafish mutants in four different receptors that respond to estrogens. He has used the mutants to help unravel a novel mechanism of estrogen action on heart physiology.